Skip to main content
Erschienen in: Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 2/2019

14.02.2019 | Herzinsuffizienz | CME

Lungenbeteiligung bei Herzkrankheiten

verfasst von: Prof. Dr. med. F. J. Meyer, S. Andreas, M. Held, H. Leuchte, H. Worth

Erschienen in: Zeitschrift für Herz-,Thorax- und Gefäßchirurgie | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Lungenbeteiligung bei Herzkrankheiten ist nicht immer eine direkte Schädigung, sondern oftmals eine Folge komplexer kardiorespiratorischer Interaktionen. Anhand 5 ausgewählter Situationen – Lungenfunktion und Ventilation im Schlaf bei chronischer Linksherzinsuffizienz, alveoläre Hämorrhagie unter Antikoagulation, infektiöse Rechtsherzendokarditis, Auswirkungen herzchirurgischer Eingriffe auf pulmonale Funktionen sowie Belastungsreaktion und Atemmuskelfunktion bei idiopathischer pulmonal arterieller Hypertonie – werden die diagnostischen und therapeutischen Herausforderungen dargestellt.
Literatur
1.
Zurück zum Zitat Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agusti A (2016) Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care. Am J Respir Crit Care Med 194(11):1319–1336PubMedCrossRef Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agusti A (2016) Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care. Am J Respir Crit Care Med 194(11):1319–1336PubMedCrossRef
2.
Zurück zum Zitat Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391(10120):572–580PubMedPubMedCentralCrossRef Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391(10120):572–580PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Chen YGH, Xu D, Xu X, Wang H, Hu X, Lu Z, Kwak D, Xu Y, Gunther R, Huo Y, Weir EK (2012) Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease. Hypertension 59:9 Chen YGH, Xu D, Xu X, Wang H, Hu X, Lu Z, Kwak D, Xu Y, Gunther R, Huo Y, Weir EK (2012) Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease. Hypertension 59:9
4.
Zurück zum Zitat Hawkins NM, Virani S, Ceconi C (2013) Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J 34(36):2795–2803PubMedCrossRef Hawkins NM, Virani S, Ceconi C (2013) Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J 34(36):2795–2803PubMedCrossRef
5.
Zurück zum Zitat Andreas S, Morguet AJ, Werner GS, Kreuzer H (1996) Ventilatory response to exercise and to carbon dioxide in patients with heart failure. Eur Heart J 17(5):750–755PubMedCrossRef Andreas S, Morguet AJ, Werner GS, Kreuzer H (1996) Ventilatory response to exercise and to carbon dioxide in patients with heart failure. Eur Heart J 17(5):750–755PubMedCrossRef
6.
7.
Zurück zum Zitat Clark AL, Poole-Wilson PA, Coats AJ (1996) Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 28(5):1092–1102PubMedCrossRef Clark AL, Poole-Wilson PA, Coats AJ (1996) Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 28(5):1092–1102PubMedCrossRef
8.
Zurück zum Zitat Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P et al (2008) The ventilatory classification system effectively predicts hospitalization in patients with heart failure. J Cardiopulm Rehabil Prev 28(3):195–198PubMedCrossRef Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P et al (2008) The ventilatory classification system effectively predicts hospitalization in patients with heart failure. J Cardiopulm Rehabil Prev 28(3):195–198PubMedCrossRef
9.
Zurück zum Zitat Apostolo ALP, Palange P, Agalbato C, Molle R, Popovic D (2015) Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Int J Cardiol 189:7CrossRef Apostolo ALP, Palange P, Agalbato C, Molle R, Popovic D (2015) Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Int J Cardiol 189:7CrossRef
10.
Zurück zum Zitat Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kubler W et al (2001) Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 103(17):2153–2158PubMedCrossRef Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kubler W et al (2001) Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 103(17):2153–2158PubMedCrossRef
11.
Zurück zum Zitat Filusch A, Ewert R, Altesellmeier M, Zugck C, Hetzer R, Borst MM et al (2011) Respiratory muscle dysfunction in congestive heart failure—the role of pulmonary hypertension. Int J Cardiol 150(2):182–185PubMedCrossRef Filusch A, Ewert R, Altesellmeier M, Zugck C, Hetzer R, Borst MM et al (2011) Respiratory muscle dysfunction in congestive heart failure—the role of pulmonary hypertension. Int J Cardiol 150(2):182–185PubMedCrossRef
12.
Zurück zum Zitat Bauer R, Dehnert C, Schoene P, Filusch A, Bartsch P, Borst MM et al (2007) Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 101(11):2366–2369PubMedCrossRef Bauer R, Dehnert C, Schoene P, Filusch A, Bartsch P, Borst MM et al (2007) Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 101(11):2366–2369PubMedCrossRef
13.
Zurück zum Zitat Haarmann H, Folle J, Nguyen XP, Herrmann P, Heusser K, Hasenfuss G et al (2016) Sympathetic activation is associated with exercise limitation in COPD. COPD 13(5):589–594PubMedCrossRef Haarmann H, Folle J, Nguyen XP, Herrmann P, Heusser K, Hasenfuss G et al (2016) Sympathetic activation is associated with exercise limitation in COPD. COPD 13(5):589–594PubMedCrossRef
14.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 37(27):2129–2200 (Developed with the special contribution of the Heart Failure Association (HFA) of the ESC)PubMedCrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 37(27):2129–2200 (Developed with the special contribution of the Heart Failure Association (HFA) of the ESC)PubMedCrossRef
15.
Zurück zum Zitat Hohlfeld JM, Vogel-Claussen J, Biller H, Berliner D, Berschneider K, Tillmann HC et al (2018) Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med 6(5):368–378PubMedCrossRef Hohlfeld JM, Vogel-Claussen J, Biller H, Berliner D, Berschneider K, Tillmann HC et al (2018) Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med 6(5):368–378PubMedCrossRef
16.
Zurück zum Zitat Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d’Ortho MP, Erdmann E et al (2016) Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med 4(11):873–881PubMedCrossRef Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d’Ortho MP, Erdmann E et al (2016) Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med 4(11):873–881PubMedCrossRef
17.
Zurück zum Zitat Kip MS, Schönfelder T, Bleß H‑H (2015) Weißbuch Schlaganfallprävention bei Vorhofflimmern. Thieme, Stuttgart Kip MS, Schönfelder T, Bleß H‑H (2015) Weißbuch Schlaganfallprävention bei Vorhofflimmern. Thieme, Stuttgart
19.
Zurück zum Zitat Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS et al (2013) Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose. Am J Kidney Dis 62(3):591–594PubMedCrossRef Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS et al (2013) Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose. Am J Kidney Dis 62(3):591–594PubMedCrossRef
20.
Zurück zum Zitat Wijnen PA, Linssen CF, Haenen GR, Bekers O, Drent M (2010) Variant VKORC1 and CYP2C9 alleles in patients with diffuse alveolar hemorrhage caused by oral anticoagulants. Mol Diagn Ther 14(1):23–30PubMedCrossRef Wijnen PA, Linssen CF, Haenen GR, Bekers O, Drent M (2010) Variant VKORC1 and CYP2C9 alleles in patients with diffuse alveolar hemorrhage caused by oral anticoagulants. Mol Diagn Ther 14(1):23–30PubMedCrossRef
21.
Zurück zum Zitat Greening AP, Hughes JM (1981) Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage. Clin Sci 60(5):507–512PubMedCrossRef Greening AP, Hughes JM (1981) Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage. Clin Sci 60(5):507–512PubMedCrossRef
22.
Zurück zum Zitat Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Tleyjeh IM, Rybak MJ et al (2015) Infective Endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486PubMedCrossRef Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Tleyjeh IM, Rybak MJ et al (2015) Infective Endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486PubMedCrossRef
23.
Zurück zum Zitat Habib G, Lancellotti P, Iung B (2016) 2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease. Heart 102(13):992–994PubMedCrossRef Habib G, Lancellotti P, Iung B (2016) 2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease. Heart 102(13):992–994PubMedCrossRef
25.
Zurück zum Zitat Szelkowski LA, Puri NK, Singh R, Massimiano PS (2015) Current trends in preoperative, intraoperative, and postoperative care of the adult cardiac surgery patient. Curr Probl Surg 52(1):531–569PubMedCrossRef Szelkowski LA, Puri NK, Singh R, Massimiano PS (2015) Current trends in preoperative, intraoperative, and postoperative care of the adult cardiac surgery patient. Curr Probl Surg 52(1):531–569PubMedCrossRef
26.
Zurück zum Zitat Urell C, Westerdahl E, Hedenstrom H, Janson C, Emtner M (2012) Lung function before and two days after open-heart surgery. Crit Care Res Pract 2012:291628PubMedPubMedCentral Urell C, Westerdahl E, Hedenstrom H, Janson C, Emtner M (2012) Lung function before and two days after open-heart surgery. Crit Care Res Pract 2012:291628PubMedPubMedCentral
27.
Zurück zum Zitat Westerdahl E, Lindmark B, Bryngelsson I, Tenling A (2003) Pulmonary function 4 months after coronary artery bypass graft surgery. Respir Med 97(4):317–322PubMedCrossRef Westerdahl E, Lindmark B, Bryngelsson I, Tenling A (2003) Pulmonary function 4 months after coronary artery bypass graft surgery. Respir Med 97(4):317–322PubMedCrossRef
28.
Zurück zum Zitat Urell C, Emtner M, Hedenstrom H, Westerdahl E (2016) Respiratory muscle strength is not decreased in patients undergoing cardiac surgery. J Cardiothorac Surg 11:41PubMedPubMedCentralCrossRef Urell C, Emtner M, Hedenstrom H, Westerdahl E (2016) Respiratory muscle strength is not decreased in patients undergoing cardiac surgery. J Cardiothorac Surg 11:41PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Taggart DP (2000) Respiratory dysfunction after cardiac surgery: effects of avoiding cardiopulmonary bypass and the use of bilateral internal mammary arteries. Eur J Cardiothorac Surg 18(1):31–37PubMedCrossRef Taggart DP (2000) Respiratory dysfunction after cardiac surgery: effects of avoiding cardiopulmonary bypass and the use of bilateral internal mammary arteries. Eur J Cardiothorac Surg 18(1):31–37PubMedCrossRef
30.
Zurück zum Zitat Altarabsheh SE, Deo SV, Dunlay SM, Erwin PJ, Obeidat YM, Navale S et al (2017) Meta-analysis of usefulness of concomitant mitral valve repair or replacement for moderate ischemic mitral regurgitation with coronary artery bypass grafting. Am J Cardiol 119(5):734–741PubMedCrossRef Altarabsheh SE, Deo SV, Dunlay SM, Erwin PJ, Obeidat YM, Navale S et al (2017) Meta-analysis of usefulness of concomitant mitral valve repair or replacement for moderate ischemic mitral regurgitation with coronary artery bypass grafting. Am J Cardiol 119(5):734–741PubMedCrossRef
31.
Zurück zum Zitat Weissman C (2004) Pulmonary complications after cardiac surgery. Semin Cardiothorac Vasc Anesth 8(3):185–211PubMedCrossRef Weissman C (2004) Pulmonary complications after cardiac surgery. Semin Cardiothorac Vasc Anesth 8(3):185–211PubMedCrossRef
32.
Zurück zum Zitat Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC et al (2014) Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score. Crit Care Med 42(5):1150–1156PubMedCrossRef Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC et al (2014) Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score. Crit Care Med 42(5):1150–1156PubMedCrossRef
33.
Zurück zum Zitat He S, Chen B, Li W, Yan J, Chen L, Wang X et al (2014) Ventilator-associated pneumonia after cardiac surgery: a meta-analysis and systematic review. J Thorac Cardiovasc Surg 148(6):3148–3155 (e1–5)PubMedCrossRef He S, Chen B, Li W, Yan J, Chen L, Wang X et al (2014) Ventilator-associated pneumonia after cardiac surgery: a meta-analysis and systematic review. J Thorac Cardiovasc Surg 148(6):3148–3155 (e1–5)PubMedCrossRef
34.
Zurück zum Zitat Stephens RS, Shah AS, Whitman GJ (2013) Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg 95(3):1122–1129PubMedCrossRef Stephens RS, Shah AS, Whitman GJ (2013) Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg 95(3):1122–1129PubMedCrossRef
35.
Zurück zum Zitat Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL (2006) Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 296(15):1851–1857PubMedCrossRef Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL (2006) Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 296(15):1851–1857PubMedCrossRef
36.
Zurück zum Zitat Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 46(4):903–975 (The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT))PubMedCrossRef Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 46(4):903–975 (The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT))PubMedCrossRef
37.
Zurück zum Zitat Meyer FJ, Ewert R, Hoeper MM, Olschewski H, Behr J, Winkler J et al (2002) Peripheral airway obstruction in primary pulmonary hypertension. Thorax 57(6):473–476PubMedPubMedCentralCrossRef Meyer FJ, Ewert R, Hoeper MM, Olschewski H, Behr J, Winkler J et al (2002) Peripheral airway obstruction in primary pulmonary hypertension. Thorax 57(6):473–476PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Laveneziana P, Humbert M, Godinas L, Joureau B, Malrin R, Straus C et al (2015) Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 45(5):1495–1498PubMedCrossRef Laveneziana P, Humbert M, Godinas L, Joureau B, Malrin R, Straus C et al (2015) Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 45(5):1495–1498PubMedCrossRef
39.
Zurück zum Zitat Naeije R (2014) Lung mechanics and exertional dyspnea in pulmonary arterial hypertension. Respiration 88(1):16–17PubMedCrossRef Naeije R (2014) Lung mechanics and exertional dyspnea in pulmonary arterial hypertension. Respiration 88(1):16–17PubMedCrossRef
40.
Zurück zum Zitat Laveneziana P, Garcia G, Joureau B, Nicolas-Jilwan F, Brahimi T, Laviolette L et al (2013) Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 41(3):578–587PubMedCrossRef Laveneziana P, Garcia G, Joureau B, Nicolas-Jilwan F, Brahimi T, Laviolette L et al (2013) Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 41(3):578–587PubMedCrossRef
41.
Zurück zum Zitat Droste AS, Rohde D, Voelkers M, Filusch A, Bruckner T, Borst MM et al (2009) Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension. Respir Res 10:129PubMedPubMedCentralCrossRef Droste AS, Rohde D, Voelkers M, Filusch A, Bruckner T, Borst MM et al (2009) Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension. Respir Res 10:129PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Meyer FJ, Lossnitzer D, Kristen AV, Schoene AM, Kubler W, Katus HA et al (2005) Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J 25(1):125–130PubMedCrossRef Meyer FJ, Lossnitzer D, Kristen AV, Schoene AM, Kubler W, Katus HA et al (2005) Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J 25(1):125–130PubMedCrossRef
43.
Zurück zum Zitat Kabitz HJ, Schwoerer A, Bremer HC, Sonntag F, Walterspacher S, Walker D et al (2008) Impairment of respiratory muscle function in pulmonary hypertension. Clin Sci 114(2):165–171PubMedCrossRef Kabitz HJ, Schwoerer A, Bremer HC, Sonntag F, Walterspacher S, Walker D et al (2008) Impairment of respiratory muscle function in pulmonary hypertension. Clin Sci 114(2):165–171PubMedCrossRef
44.
Zurück zum Zitat Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104(4):429–435PubMedCrossRef Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104(4):429–435PubMedCrossRef
46.
Zurück zum Zitat Richter MJ, Tiede H, Morty RE, Voswinckel R, Seeger W, Schulz R et al (2014) The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration 88(1):24–30PubMedCrossRef Richter MJ, Tiede H, Morty RE, Voswinckel R, Seeger W, Schulz R et al (2014) The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration 88(1):24–30PubMedCrossRef
47.
Zurück zum Zitat Richter MJ, Voswinckel R, Tiede H, Schulz R, Tanislav C, Feustel A et al (2012) Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension. Respir Med 106(2):308–313PubMedCrossRef Richter MJ, Voswinckel R, Tiede H, Schulz R, Tanislav C, Feustel A et al (2012) Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension. Respir Med 106(2):308–313PubMedCrossRef
48.
Zurück zum Zitat Meyer FJ, Borst MM, Buschmann HC, Ewert R, Friedmann-Bette B, Ochmann U et al (2013) Exercise testing in respiratory medicine. Pneumologie 67(1):16–34PubMedCrossRef Meyer FJ, Borst MM, Buschmann HC, Ewert R, Friedmann-Bette B, Ochmann U et al (2013) Exercise testing in respiratory medicine. Pneumologie 67(1):16–34PubMedCrossRef
49.
Zurück zum Zitat Yan S, Kaminski D, Sliwinski P (1997) Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156(1):55–59PubMedCrossRef Yan S, Kaminski D, Sliwinski P (1997) Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156(1):55–59PubMedCrossRef
50.
Zurück zum Zitat Criee CP, Baur X, Berdel D, Bosch D, Gappa M, Haidl P et al (2015) Standardization of spirometry: 2015 update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine. Pneumologie 69(3):147–164PubMedCrossRef Criee CP, Baur X, Berdel D, Bosch D, Gappa M, Haidl P et al (2015) Standardization of spirometry: 2015 update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine. Pneumologie 69(3):147–164PubMedCrossRef
51.
Zurück zum Zitat Naeije R (2005) Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J 25(1):6–8PubMedCrossRef Naeije R (2005) Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J 25(1):6–8PubMedCrossRef
Metadaten
Titel
Lungenbeteiligung bei Herzkrankheiten
verfasst von
Prof. Dr. med. F. J. Meyer
S. Andreas
M. Held
H. Leuchte
H. Worth
Publikationsdatum
14.02.2019
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie / Ausgabe 2/2019
Print ISSN: 0930-9225
Elektronische ISSN: 1435-1277
DOI
https://doi.org/10.1007/s00398-019-0296-4

Weitere Artikel der Ausgabe 2/2019

Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 2/2019 Zur Ausgabe

Karriere und Perspektiven

Interventioneller Herzchirurg

Historische Profile

Maude E. Abbott